Mood swings, irritability, anxiety, and even mild depressive symptoms can arise after stopping Semaglutide
The cardiovascular protective mechanisms of GLP-1 receptor agonists are thought to include: Improved glycaemic control , reducing endothelial dysfunction associated with hyperglycaemia Weight reduction , decreasing metabolic stress and inflammation Blood pressure lowering , potentially through effects on fluid balance and vascular function Favourable lipid profile changes , including modest reductions in LDL cholesterol and triglycerides Anti-inflammatory effects , reducing systemic markers of inflammation such as C-reactive protein Regulatory bodies including the MHRA and EMA have not identified thrombotic events as a specific safety concern with GLP-1 receptor agonists
Yes, some medicines can be used with keto, but not all work the same way
Protein shakes designed for GLP-1 users can help bridge the gap between actual intake and recommended targets
Ozempic is the poster child, the name we all know, but we now prescribe Wegovy, Monjouro and Zepbound for weight loss more because they are more effective for both weight loss and tolerance, she says
If true, this would have profound implications for longevity